Challenging problems in advanced malignancy - Case 3. Imatinib mesylate-induced interstitial pneumonitis

被引:29
作者
Rosado, MF [1 ]
Donna, E [1 ]
Ahn, YS [1 ]
机构
[1] Sylvester Canc Ctr, Miami, FL USA
关键词
D O I
10.1200/JCO.2003.03.037
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:3171 / 3173
页数:3
相关论文
共 6 条
[1]   Hypersensitivity pneumonitis related to imatinib mesylate [J].
Bergeron, A ;
Bergot, E ;
Vilela, G ;
Ades, L ;
Devergie, A ;
Espérou, H ;
Socié, G ;
Calvo, F ;
Gluckman, E ;
Ribaud, P ;
Rousselot, P ;
Tazi, A .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) :4271-4272
[2]   Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037
[3]   Unexpected pleural effusions in 3 pediatric patients treated with STI-571 [J].
Goldsby, R ;
Pulsipher, M ;
Adams, R ;
Coffin, C ;
Albritton, K ;
Wagner, L .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (08) :694-695
[4]  
*NOV PHARM CORP, 2002, GLEEV IM MES
[5]  
Ottmann OG, 2000, BLOOD, V96, p828A
[6]   Drug therapy: Imatinib mesylate - A new oral targeted therapy. [J].
Savage, DG ;
Antman, KH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :683-693